SNORD107: A Small Nucleolar RNA as a Drug Target and Biomarker

Target Name: SNORD107

NCBI ID: G91380

SNORD107

Other Name(s): small nucleolar RNA, C/D box 107 | Small nucleolar RNA, C/D box 107 | HBII-436

SNORD107: A Small Nucleolar RNA as a Drug Target and Biomarker

Small nucleolar RNA (snRNA) is a non-coding RNA molecule that plays a crucial role in the regulation of gene expression in eukaryotic cells. One of the key functions of snRNA is to help maintain the stability of the endoplasmic reticulum (ER), which is responsible for the storage and degradation of proteins. One of the well-known snRNAs is SNORD107, which is expressed in various cell types and is involved in the regulation of gene expression.

SNORD107 is a C/D box snRNA that is characterized by its ability to form a double helix with other snRNAs. It is a key component of the heterochromatin fraction and is involved in the regulation of gene expression. SNORD107 has been shown to play a role in the regulation of various cellular processes, including cell growth, apoptosis, and translation.

Drug Target

SNORD107 has been identified as a potential drug target due to its involvement in the regulation of cellular processes that are relevant to various diseases. One of the key targets of SNORD107 is the regulation of cell apoptosis, which is the process by which cells undergo programmed cell death. SNORD107 has been shown to play a role in the regulation of apoptosis by promoting the expression of genes that are involved in the formation of the apoptotic machinery.

Another potential drug target for SNORD107 is its role in the regulation of cell growth. SNORD107 has been shown to play a negative role in the regulation of cell growth by promoting the translation of genes that are involved in cell growth inhibition. This suggests that SNORD107 may be an attractive target for drugs that are designed to promote cell growth.

Biomarker

SNORD107 has also been identified as a potential biomarker for various diseases. One of the key applications of SNORD107 is its ability to be used as a tool for the diagnosis and prognosis of various diseases. For example, studies have shown that SNORD107 levels are often reduced in cancer cells compared to normal cells, which may be a potential biomarker for cancer.

Another application of SNORD107 is its potential as a biomarker for neurodegenerative diseases. Studies have shown that SNORD107 levels are often reduced in individuals with Alzheimer's disease and other forms of neurodegenerative disease, which may be a potential biomarker for these diseases.

Conclusion

SNORD107 is a small nucleolar RNA that is involved in the regulation of various cellular processes. Its potential as a drug target and biomarker makes it an attractive target for research into the development of new therapies for various diseases. Further studies are needed to fully understand the role of SNORD107 in cellular processes and its potential as a drug target and biomarker.

Protein Name: Small Nucleolar RNA, C/D Box 107

The "SNORD107 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SNORD107 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets